Vemircopan (ALXN2050) is an orally active complement factor D inhibitor[1].
[1]. Claire L Harris, et al. Developments in anti-complement therapy; from disease to clinical trial. Mol Immunol. 2018 Oct;102:89-119.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 5 mg | ¥10,350.00 | 现货 | 1 | |
| 10 mg | ¥16,650.00 | 现货 | 1 | |
| 25 mg | ¥33,120.00 | 现货 | 1 | |
| 50 mg | ¥53,100.00 | 现货 | 1 | |
| 100 mg | ¥86,400.00 | 现货 | 1 |
















Vemircopan (ALXN2050) is an orally active complement factor D inhibitor[1].
[1]. Claire L Harris, et al. Developments in anti-complement therapy; from disease to clinical trial. Mol Immunol. 2018 Oct;102:89-119.